Alanna Stanley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alanna Stanley has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Joanne O'DWyer
Discipline of Pharmacology and Therapeutics, School of Medicine, Human Biology Building, University of Galway , University Road, Galway H91 W5P7
1 shared publication Pascal Paco Farina
Discipline of Anatomy, School of Medicine, Human Biology Building, University of Galway , University Road, Galway H91 W5P7
1 shared publicationPeter Dockery
Discipline of Anatomy, School of Medicine, Human Biology Building, University of Galway , University Road, Galway H91 W5P7
1 shared publication- Rachel Beatty
Anatomy, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway
1 shared publication
Latest Publications
- Open Access
- 15 July 2025
- Published by Oxford University Press (OUP) in Microscopy and Microanalysis
- Vol. 31 (4)
Understanding the Impact of Reperfusion in the Development of a Safe Compression Therapy
The benefits of an intermittent compression therapy are known; however, in some circumstances, it results in soft-tissue injuries. This study aims to create a model for testing the safety, efficacy, and molecular mechanisms of a compression therapy, without creating an injury. Existing ischemia/reperfusion protocols were modified to apply repeated compression without forming a pressure ulcer. The skin of immobilized C57BL/6 male mice was pinched between two magnets (3 h, 2–3 days of recovery between treatments). Hair growth was stunted but started to regrow within 18 days. The application of pressure caused an increase in epidermal thickness (****p = 0.002), CD31+ total number (**p = 0.0021), and increased radial diffusion distance (*p = 0.0285). Pressure caused a reduction in adipocyte volume weight mean volume (****p < 0.0001) and CD34 volume fraction (*p = 0.0460). Stem cell populations (cytokeratin 15; p = 0.4992, CD34; p = 0.6873 and integrin α-6; p = 0.7752) were unaffected. Importantly, pressure did not increase markers of DNA damage (p53; p = 0.7524 and caspase 3; p = 0.0839), indicating that this compression model had limited negative effects on the tissue. The altered protocol successfully created a model to permit the analysis of uninjured skin after pressure is applied.
- 15 July 2025
- Published by Oxford University Press (OUP) in Microscopy and Microanalysis
- Vol. 31 (4)
Open AccessUnderstanding the Impact of Reperfusion in the Development of a Safe Compression Therapy
The benefits of an intermittent compression therapy are known; however, in some circumstances, it results in soft-tissue injuries. This study aims to create a model for testing the safety, efficacy, and molecular mechanisms of a compression therapy, without creating an injury. Existing ischemia/reperfusion protocols were modified to apply repeated compression without forming a pressure ulcer. The skin of immobilized C57BL/6 male mice was pinched between two magnets (3 h, 2–3 days of recovery between treatments). Hair growth was stunted but started to regrow within 18 days. The application of pressure caused an increase in epidermal thickness (****p = 0.002), CD31+ total number (**p = 0.0021), and increased radial diffusion distance (*p = 0.0285). Pressure caused a reduction in adipocyte volume weight mean volume (****p < 0.0001) and CD34 volume fraction (*p = 0.0460). Stem cell populations (cytokeratin 15; p = 0.4992, CD34; p = 0.6873 and integrin α-6; p = 0.7752) were unaffected. Importantly, pressure did not increase markers of DNA damage (p53; p = 0.7524 and caspase 3; p = 0.0839), indicating that this compression model had limited negative effects on the tissue. The altered protocol successfully created a model to permit the analysis of uninjured skin after pressure is applied.